Table 1 Characteristics of included studies
From: Mortality and mode of dialysis: meta-analysis and systematic review
Author (Year) | Design | Inclusion criteria | n (% male) | Mean/median age | Duration | Mortality |
|---|---|---|---|---|---|---|
Continuous Renal Replacement Therapy (CRRT) versus Peritoneal Dialysis (PD) | ||||||
 Al-Hwiesh et al. [27] (2018) | RCT | • AKI requiring KRT | CRRT = 62 (72.6%) PD = 63 (74.6%) | CRRT = 44.6 ± 12.4 PD = 45.4 ± 4.1 | 28 days | CRRT = 53.2% PD = 30.2% |
 George et al. [28] (2011) | RCT | • AKI • No history of abdominal surgery • No pulmonary edema | CRRT = 25 (60%) PD = 25 (64%) | CRRT = 45.3 ± 17.5 PD = 45.3 ± 17.5 | 3 years | CRRT = 84% PD = 72% |
 Jaryal et al. [29] (2017) | R-Obs | • > 12 years • GFR < 60 ml/min/1.73m2 | CRRT = 22 (50%) PD = 18 (66.7%) | CRRT = 55.5 ± 19 PD = 51.1 ± 16 | 1 year | CRRT = 81.8% PD = 77.8% |
 Phu et al. [30] (2002) | RCT | • > 15 years • AKI requiring KRT | CRRT = 34 (88%) PD = 36 (75%) | CRRT = 35 (29.5–38.2) PD = 36 (29.6–38.4) | 1 year | CRRT = 15% PD = 47% |
Peritoneal Dialysis (PD) versus Hemodialysis (HD) | ||||||
 Basu et al. [31] (2016) | R-Obs | • 1 month to 16 years • Uremia, oliguria, anuria, and severe metabolic acidosis • Non-responsive fluid overload, • Persistent hyponatremia | PD = 84 (51%) HD = 52 (67%) | PD = 3.2 (0.1–7.6) HD = 8.4 (3.2–15.6) | 30 days | PD = 39.3% HD = 66.3% |
 Fenton et al. [32] (1997) | R-Obs | • ESRD • No history of dialysis or kidney transplant | PD = 2841 (NR) HD = 7792 (NR) | NR | 5 years | PD = 26.2% HD = 30.9% |
 Gabriel et al. [33] (2008) | RCT | • With acute tubular necrosis | PD = 60 (72%) HD = 60 (66%) | PD = 62.5 ± 21.2 HD = 64.2 ± 19.8 | 60 days | PD = 58% HD = 53% |
 Murphy et al. [34] (2000) | P-Obs | • Patients with renal failure of any kind | PD = 282 (59.9%) HD = 540 (58.7%) | PD = 56.1 (54.2–58.0) HD = 59.4 (58.1–60.7) | 6 months | PD = 33.8% HD = 39.8% |
 He et al. [35] (2020) | R-Obs | • Patient with ESRD | PD = 501 (58%) HD = 436 (53.9%) | PD = 51.69 ± 14.47 HD = 57.11 ± 15.92 | 5 years | PD = 4% HD = 21% |
 Liem et al. [36] (2007) | R-Obs | • > 18 years • Requiring > 30 days KRT | PD = 5802 (61.3%) HD = 10,841 (57.5%) | PD = 53.6 ± 15 HD = 61.8 ± 14.6 | 6 months | Hazard ratio (PD vs. HD) = 0.70 (95% CI 0.67–0.74) |
Hemodialysis (HD) versus Continuous Renal Replacement Therapy (CRRT) | ||||||
 Gaudry et al. [15] (2022) | RCT | • AKI requiring KRT | HD = 274 (63.9%) CRRT = 269 (62.4%) | HD = 66.8 ± 13.3 CRRT = 66.2 ± 13.4 | 60 days | HD = 46.3% CRRT = 54.3% |
 Liang et al. [37] (2016) | R-Obs | • No history of chronic kidney dialysis, transplant, or heart failure • Creatinine level < 4 mg/dl | HD = 353 (57.5%) CRRT = 285 (58.6%) | NR | 90 days | HD = 55.9% CRRT = 60% |
 Schefold et al. [38] (2014) | RCT | • > 18 years • AFR requiring KRT | HD = 128 (63.3%) CRRT = 122 (61.5%) | HD = 60.8 ± 13.4 CRRT = 62.3 ± 14.5 | 30 days | HD = 52.4% CRRT = 45.4% |
 Truche et al. [39] (2016) | P-Obs | • Patients who received MV for ≥ 48 h in an ICU setting • No history of kidney transplant, CKD requiring KRT, or heart disease | HD = 816 (65%) CRRT = 544 (63.6%) | HD = 66.4 (54.8–76.1) CCRT = 64.3 (52.4–74.3) | 30 days | CRRT = 46.5% HD = 35% |
 Yilmaz Aydin et al. [40] (2022) | P-Obs | • AKI requiring KRT • No history of CKD or ESRD | HD = 80 (38.7%) CRRT = 40 (37.5%) | HD = 61.4 ± 15.2 CRRT = 65.9 ± 9.1 | 30 days | HD = 66.3% CRRT = 67.5% |